EVALUATION OF THE NK1 RECEPTOR ANTAGONIST SERLOPITANT IN PATIENTS WITH OVERACTIVE BLADDER

被引:0
|
作者
Frenkl, Tara L.
Seltzer, Olga
Zhu, Haiyuan
Reiss, Theodore F.
Green, Stuart A.
Green, Stuart A.
机构
来源
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词
D O I
10.1016/S0022-5347(09)61895-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1873
引用
收藏
页码:676 / 676
页数:1
相关论文
共 50 条
  • [21] Evaluation of PD154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain
    Gonzalez, M
    Field, MJ
    Holloman, EF
    Hughes, J
    Oles, RJ
    Singh, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 344 (2-3) : 115 - 120
  • [22] NK1 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (04) : 191 - 191
  • [23] The NK1 Receptor Antagonist L822429 Reduces Heroin Reinforcement
    Barbier, Estelle
    Vendruscolo, Leandro F.
    Schlosburg, Joel E.
    Edwards, Scott
    Juergens, Nathan
    Park, Paula E.
    Misra, Kaushik K.
    Cheng, Kejun
    Rice, Kenner C.
    Schank, Jesse
    Schulteis, Gery
    Koob, George F.
    Heilig, Markus
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (06) : 976 - 984
  • [24] CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST
    GITTER, BD
    WATERS, DC
    THRELKELD, PG
    LOVELACE, AM
    MATSUMOTO, K
    BRUNS, RF
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (03): : 439 - 446
  • [25] Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin
    Kris, MG
    Radford, JE
    Pizzo, BA
    Inabinet, R
    Hesketh, A
    Hesketh, PJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (11) : 817 - 818
  • [26] The NK1 Receptor Antagonist L822429 Reduces Heroin Reinforcement
    Estelle Barbier
    Leandro F Vendruscolo
    Joel E Schlosburg
    Scott Edwards
    Nathan Juergens
    Paula E Park
    Kaushik K Misra
    Kejun Cheng
    Kenner C Rice
    Jesse Schank
    Gery Schulteis
    George F Koob
    Markus Heilig
    Neuropsychopharmacology, 2013, 38 : 976 - 984
  • [27] Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret
    Minami, M
    Endo, T
    Kikuchi, K
    Ihira, E
    Hirafuji, M
    Hamaue, N
    Monma, Y
    Sakurada, T
    Tan-No, K
    Kisara, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 363 (01) : 49 - 55
  • [28] Spinal neurokinin NK1 receptor down-regulation and antinociception: Effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy
    Hua, XY
    Chen, P
    Polgar, E
    Nagy, I
    Marsala, M
    Phillips, E
    Wollaston, L
    Urban, L
    Yaksh, TL
    Webb, M
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 (02) : 688 - 698
  • [29] INVESTIGATION OF THE SPECIFICITY OF FK-888 AS A TACHYKININ NK1 RECEPTOR ANTAGONIST
    WANG, ZY
    TUNG, SR
    STRICHARTZ, GR
    HAKANSON, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (04) : 1342 - 1346
  • [30] NOVEL μ AGONIST, δ ANTAGONIST AND NK1 ANTAGONIST PEPTIDE CHIMERAS
    Kumarasinghe, J.
    Hruby, V.
    Tumati, S.
    Varga, E.
    Lai, J.
    Porecca, F.
    BIOPOLYMERS, 2009, 92 (04) : 322 - 323